When antipsychotics are necessary and what they actually do

They are not personality erasers. They are not addictive. What they are is effective for psychosis.

For patients and families in Chicago PMHNP evaluation: This article reflects clinical evidence and direct experience. If you're in the Chicago area or Illinois, contact me to discuss your concerns.

Antipsychotic medications are among the most misunderstood drugs in psychiatry.

The public image is of a chemical straitjacket — something that flattens personality, removes volition, and produces dependence. The clinical reality is considerably different, and the gap between image and reality keeps people untreated.

What antipsychotics actually do

Antipsychotics reduce psychotic symptoms: hallucinations, delusions, disorganized thinking, and the distress that accompanies them. They do this by modulating dopamine and sometimes other neurotransmitters.

They do not remove someone's personality. They do not produce dependence in the pharmacological sense — there is no withdrawal syndrome or escalating dose requirement. They do not make someone a different person.

What they do is stop the psychosis, which often means someone can think clearly, engage with others, and function for what feels like the first time.

When they are indicated

Antipsychotics are front-line treatment for schizophrenia, schizoaffective disorder, and psychotic episodes in bipolar disorder. They are also used in some depression, in acute agitation and aggression, and in some cases of severe anxiety.

The key question is whether psychosis or severe agitation is present. If it is, antipsychotics have stronger evidence than any alternative.

The side effect question

Antipsychotics do have side effects, and they deserve serious discussion rather than minimization.

First-generation (typical) antipsychotics carry significant movement-related side effects: tremor, rigidity, akathisia, and tardive dyskinesia. These were the main reason the class was feared, and rightfully so.

Second-generation (atypical) antipsychotics have lower movement risk but higher metabolic risk: weight gain, glucose dysregulation, lipid changes. This requires monitoring and is worth discussing openly. Some agents carry more metabolic risk than others.

The central point: these side effects are real, they are monitored, and they are sometimes worth tolerating because the untreated psychosis is worse. The comparison is never between antipsychotics and nothing. It is between antipsychotics with side effects and psychosis without treatment.

Long-acting injectables as an option

For people with schizophrenia or schizoaffective disorder who have missed doses or stopped treatment, long-acting injectable antipsychotics can be substantially helpful. They provide coverage over weeks without requiring daily adherence.

These should be offered as an option, not imposed. But for someone who has struggled with medication adherence, they can be genuinely life-changing.

Monitoring matters

Responsible antipsychotic prescribing includes baseline assessment, regular metabolic monitoring, movement assessments, and discussion of side effects. If a clinician is not doing this, that is information about the clinician, not about whether the medication is appropriate.

The untreated version

Untreated psychosis is also not free of cost. It carries risk of harm, of social and occupational consequences, and of the person developing increasingly complex beliefs that make eventual treatment harder.

A person on an antipsychotic with weight gain and some metabolic changes is in a better position than someone whose psychosis has shaped their life around false beliefs for a decade.

Published August 2026 · Reviewed for accuracy against the sources listed above.